Literature DB >> 20002854

Outpatient parenteral antimicrobial therapy-treated bone and joint infections in a tropical setting.

H A White1, J S Davis, P Kittler, B J Currie.   

Abstract

BACKGROUND: Osteoarticular infections are a primary indication for outpatient parenteral antimicrobial therapy (OPAT). The climate and geographical diversity of tropical Australia, together with the prevalence of melioidosis, disseminated gonococcal disease and community-acquired methicillin-resistant Staphylococcus aureus renders this a challenging environment in which to manage such infections. We evaluated patients managed by the Royal Darwin Hospital Hospital in the Home service for bone and joint infections.
METHODS: A retrospective analysis of the therapeutic outcomes at the end of intravenous therapy was carried out for patients treated between 1 January 2006 and 15 September 2007.
RESULTS: Fifty-five patients were treated, including 21 (38%) indigenous Australians and 18 (33%) from remote communities. Baseline characteristics were similar to other published data, but there were two cases each of gonococcal septic arthritis and melioidosis. During treatment, 39 (71%) lived at home, with five (9%) of these receiving treatment at community clinics. Thirteen (24%) resided in self-care units in the hospital grounds. Three (5%) were managed at hostels or in prison. Median duration of parenteral therapy was 42 days, with a median of 22 days outside hospital, providing a total saving of 1307 bed-days. Clinical success at end of therapy was 84%, with no significant difference between indigenous and non-indigenous cohorts.
CONCLUSION: OPAT for osteoarticular infections is both feasible and effective in a tropical environment, including for indigenous patients. Extension of treatment to remote-dwelling patients is facilitated by the innovative use of self-care units and administration of treatment at remote clinics.
© 2011 The Authors. Internal Medicine Journal © 2011 Royal Australasian College of Physicians.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20002854     DOI: 10.1111/j.1445-5994.2009.02136.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  5 in total

1.  Outpatient parenteral antibiotic therapy in a suburban tertiary referral centre in Australia over 10 years.

Authors:  Wenlong Li; James Branley; Archana Sud
Journal:  Infection       Date:  2018-02-20       Impact factor: 3.553

Review 2.  Incidence, characteristics, and outcomes of patients with bone and joint infections due to community-associated methicillin-resistant Staphylococcus aureus: a systematic review.

Authors:  K Z Vardakas; I Kontopidis; I D Gkegkes; P I Rafailidis; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-20       Impact factor: 3.267

Review 3.  Burkholderia Pseudomallei Causing Bone and Joint Infections: A Clinical Update.

Authors:  Nadeem Sajjad Raja; Christine Scarsbrook
Journal:  Infect Dis Ther       Date:  2016-01-04

Review 4.  Clinical and cost-effectiveness, safety and acceptability of community intravenous antibiotic service models: CIVAS systematic review.

Authors:  E D Mitchell; C Czoski Murray; D Meads; J Minton; J Wright; M Twiddy
Journal:  BMJ Open       Date:  2017-04-20       Impact factor: 2.692

5.  A Retrospective Case-Series of Children With Bone and Joint Infection From Northern Australia.

Authors:  Anna Brischetto; Grace Leung; Catherine S Marshall; Asha C Bowen
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.